Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 22, 2018. The report serves as a notification of provisional dividend dates for the fiscal year 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to corporate governance announcements regarding shareholder distributions.
Material Changes
No material changes to financial performance or operations are reported in this filing. The content is restricted to the scheduling of future dividend payments.
Guidance, Outlook, and Management Commentary
GSK has announced the following provisional dividend schedule for 2019. Management notes that these dates are indicative and may be subject to change.
- Q1 2019: Ex-dividend May 16; Payment July 11.
- Q2 2019: Ex-dividend August 8; Payment October 10.
- Q3 2019: Ex-dividend November 14; Payment January 9, 2020.
- Q4 2019 (Final): Ex-dividend February 20, 2020; Payment April 9, 2020.
Investor Verification Checklist
- Verify the final dividend dates against subsequent official announcements, as the current schedule is provisional.
- Confirm the ex-dividend dates to ensure eligibility for the respective quarterly payments.
- Review the full 2018 annual report (Form 20-F) for comprehensive financial metrics not included in this 6-K filing.